We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
US analyst rating / recommendation change.
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
US analyst rating / recommendation change.
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $19 · 1 analysts
Stored first · Google News · Yahoo Finance (English)
Is Marten Transport (MRTN) Stock Outpacing Its Transportation Peers This Year? - Yahoo! Finance Canada
Is Marten Transport (MRTN) Stock Outpacing Its Transportation Peers This Year? Yahoo! Finance Canada
Is Marten Transport (MRTN) Stock Outpacing Its Transportation Peers This Year?
MRTN Q2'26 Earnings: revenue estimate is 227.10M USD - TradingView
MRTN Q2'26 Earnings: revenue estimate is 227.10M USD TradingView
MRTN: What does Argus have to say about MRTN?
Enterprise value to EBIT forward of Marten Transport, Ltd. – NASDAQ:MRTN - TradingView
Enterprise value to EBIT forward of Marten Transport, Ltd. – NASDAQ:MRTN TradingView
(MRTN) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
(MRTN) as a Liquidity Pulse for Institutional Tactics Stock Traders Daily
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 07. 22. | After market close (AMC) | $0.07 | — | — | $225.65M | — | Scheduled |
| FY2025 Q1 | 2024. 03. 31. | Time TBD | — | $0.12 | — | — | $249.67M | Reported |
| FY2024 Q3 | 2023. 09. 30. | Time TBD | — | $0.71 | — | — | $863.23M | Reported |
| FY2024 Q2 | 2023. 06. 30. | Time TBD | — | $0.55 | — | — | $583.7M | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2025. 01. 29. | Stephens & Co. | — | Maintain | Overweight → Overweight | — | Stephens & Co.: Overweight |
| 2024. 10. 15. | Raymond James | — | Downgrade | Outperform → Market Perform | — | Raymond James: Outperform → Market Perform |
| 2024. 04. 19. | Stephens & Co. | — | Maintain | Overweight → Overweight | — | Stephens & Co.: Overweight |
| 2024. 01. 11. | Vertical Research | — | Upgrade | Hold → Buy | — | Vertical Research: Hold → Buy |
| 2023. 07. 20. | Stephens & Co. | — | Maintain | Overweight → Overweight | — | Stephens & Co.: Overweight |
| 2023. 05. 19. | Stephens & Co. | — | Maintain | Overweight → Overweight | — | Stephens & Co.: Overweight |
As of FY2026Q1 · Source: SEC/DART + price data
No holdings data to show.